ClinicalTrials.Veeva

Menu

Effects of Obesity on COPD

R

Rijnstate Hospital

Status

Completed

Conditions

Chronic Obstructive Pulmonary Disease
Obesity
COPD

Study type

Observational

Funder types

Other

Identifiers

NCT06474858
2014/113

Details and patient eligibility

About

The purpose of this study is to investigate whether obese COPD patients experience more or less discomfort in daily life. Furthermore the investigators will evaluate if body composition or body fat distribution has effects on symptoms and performance.

Full description

Chronic Obstructive Pulmonary Disease (COPD) and Obesity are two major health problems. The prevalence of both is growing and there is a complex interaction between COPD and obesity. On the one hand obesity impairs lung function, with decreasing static lung volumes being the most significant effect. On the other hand there seems a beneficial role of obesity on lung function in COPD patients. This is because obese COPD patients tend to have less hyperinflation than non-obese COPD patients . An interesting question is what the net effect of these changes in lung function is on respiratory symptoms and quality of life.

In this observational study, the investigators will compare obese and non-obese COPD patients. Pulmonary function, dyspnea and quality of life will be compared between the two groups.

Enrollment

166 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed with COPD by a Pulmonologist defined as an obstructive lung function test with FEV1/FVC < 0.7 and FEV1 < 80% predicted
  • No exacerbation of COPD at time of inclusion
  • Age > 18 years
  • Able to perform lung function tests and fill in the questionnaires.

Exclusion criteria

  • Not able to perform lung function tests or fill in the questionnaires
  • Diagnosis of Asthma
  • Diagnosis of neuromuscular disease
  • Diagnosis of heart failure
  • Treatment for lung Malignancy in the past
  • Active Malignancy

Trial design

166 participants in 2 patient groups

Normal weight
Description:
COPD patients with BMI 18.5-24.99
Obese
Description:
COPD patients with BMI ≥ 30

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems